BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SVACS - ECPv6.15.1.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.siliconvalleyacs.org
X-WR-CALDESC:Events for SVACS
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220908T110000
DTEND;TZID=America/Los_Angeles:20220908T120000
DTSTAMP:20260614T071726
CREATED:20220906T005000Z
LAST-MODIFIED:20220906T005000Z
UID:19030-1662634800-1662638400@www.siliconvalleyacs.org
SUMMARY:From Wood Pulp to a Candidate Medicine: Green Manufacturing Technologies Enable Production of Nemtabrutinib
DESCRIPTION:Ben Turnbull and Mike Di Maso\, Associate Principal Scientists at Merck\nSponsored by ACS Webinars and ACS Green Chemistry Pharmaceutical Roundtable\nSeptember 8th\, 11-Noon\, Online via Zoom\, Free\, Registration required\n\n\n\n\nGreen manufacturing technologies including biocatalysis\, enzyme immobilization\, and continuous manufacturing in a packed-bed reactor enabled Merck to produce investigational leukemia drug nemtabrutinib from a biorenewable starting material while reducing an 11-step synthesis down to just two steps! If these green technologies are the future of efficient manufacturing processes\, how can all pharmaceutical companies replicate this sustainability success and support the long-term supply of necessary medicines and vaccines? \nJoin Associate Principal Scientists Ben Turnbull and Mike Di Maso of Merck\, part of the team that won the 2022 Peter J. Dunn Award for Green Chemistry and Engineering Impact in the Pharmaceutical Industry\, as they explain how they leveraged these green manufacturing technologies to efficiently manufacture nemtabrutinib from a biorenewable commodity material to sustainably push forward this investigational treatment for leukemia. \nThis ACS Webinar is moderated by Philippa (Pippa) Payne of Gilead Sciences and co-produced with the ACS Green Chemistry Pharmaceutical Roundtable. \n\n\n\n\n\n\nWhat You Will Learn\n\nHow an 11-step synthesis was reduced to just two steps!\nHow toxic solvents were replaced with a biorenewable to avoid a highly energy-intensive transformation and employ catalysis to improve efficiency\nHow three green manufacturing technologies were effectively employed to contribute to the sustainability of the process\n\n\n\n\n\n\n\nWebinar Details\n\nThursday\, September 8\, 2022 @ 2-3pm ET\nFree to Register with ACS ID\nSlides will be available to download on the day of the webinar
URL:https://www.siliconvalleyacs.org/event/from-wood-pulp-to-a-candidate-medicine-green-manufacturing-technologies-enable-production-of-nemtabrutinib/
LOCATION:Virtual
CATEGORIES:ACS Webinars
ATTACH;FMTTYPE=image/jpeg:https://www.siliconvalleyacs.org/wp-content/uploads/2022/09/From-Wood-Pulp-to-Candidate-Medicine.jpg
END:VEVENT
END:VCALENDAR